-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqISIN US60770K1079-
Moderna IncBörse NasdaqISIN US60770K1079 WKN: A2N9D9Symbol MRNA
-
ModernaBörse Börse FrankfurtISIN US60770K1079 WKN: A2N9D9EURSymbol 0QF
-
ModernaBörse Börse BerlinEURSymbol 0QF
-
ModernaBörse Börse StuttgartEURSymbol 0QF
-
ModernaBörse Börse MünchenEURSymbol 0QF
-
ModernaBörse Börse HamburgEURSymbol 0QF
-
ModernaBörse Xetra FrankfurtEURSymbol 0QF
-
ModernaBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 0QF
-
ModernaBörse Quotrix System der Börse DüsseldorfEURSymbol 0QF
-
ModernaBörse Gettex System der Börse MünchenEURSymbol 0QF
-
ModernaBörse Börse DüsseldorfEURSymbol 0QF
-
ModernaBörse Bolsa Mexicana de Valore Mexiko-StadtMXNSymbol MRNA
-
Moderna, Inc.Börse BVMF
-
Moderna, Inc.Börse Bolsa Mexicana de Valore Mexiko-Stadt
-
Moderna, Inc.Börse London Stock Exchange
-
ISIN US60770K1079
WKN A2N9D9
Symbol MRNA
Börse
Nasdaq Zeitzone: Europe/Berlin
Mitarbeiter
3.900
Moderna underperformed den DAX um -39 % vom 11.08.2021 bis 31.12.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 117,86 USD +0,51%
Letzte Communitymeinungen
- Ein User war zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
Zockrat
29.08.2021
Ein User hat Moderna abonniert.
Aktionärsstruktur der Moderna
Portrait der Moderna Aktie
Das Unternehmen Moderna aus USA beschäftigt 3.900 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Die Moderna Aktie konnte seit dem 11.08.2021 leider keine Rendite erwirtschaften. Die Kursverluste lagen bei -38%.
Moderna ist in mehr als 39 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Moderna mit 12,47% im ETF.
Entdecke die 6 ETFs in denen Moderna am höchsten gewichtet ist Insgesamt in 39 ETFs enthalten
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Moderna?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
892 News & Informationen zur Moderna Aktie
Second Covid vaccine wins EU approval
Ireland in line for initial supply of 880,000 doses of Moderna vaccine
European drugs regulator approves Moderna coronavirus vaccine
Following the green light from the European Medicines Agency (EMA), the final step is approval by the European Commission which is expected to quickly follow.
Covid variant found in South Africa is worrying experts: Here’s what we know so far
A new strain of the coronavirus that has emerged in South Africa is causing concern around the globe.
Moderna: Kann der neue Impfstoff die Misere in Deutschland beenden?
Die Zulassung des Covid-Impfstoffes von Moderna steht bevor. Die EMA hat grünes Licht für Europa gegeben. Wird damit jetzt alles gut?
Many Covid stocks will not sustain growth in a post-pandemic world, Jim Cramer says
Unsustainable pandemic winners must be trimmed, if not sold, before the coronavirus pandemic ends, the “Mad Money” host said.
Moderna : Ambulances put on alert as Los Angeles hospitals swamped by COVID-19 patients
Los Angeles health officials
have told first responders to stop bringing adult patients who
cannot be resuscitated to hospitals for treatment, citing a
shortage of beds and medical staff, as the… | January 5, 2021
Israel to enter third national lockdown despite successful Covid vaccination campaign
Israel braces for a third national lockdown even with the nation seeing success in the rollout of the Pfizer BioNTech vaccine
EU In Talks To Buy Up To 300M More Coronavirus Vaccine Doses From Pfizer-BioNTech
With the U.K. entering a third nationwide lockdown and the COVID-19 pandemic raging through the rest of Europe, vaccines approved for emergency use …
Is Moderna (MRNA) Outperforming Other Medical Stocks This Year?
Is (MRNA) Outperforming Other Medical Stocks This Year?
Moderna Raises Covid-19 Vaccine Production Estimate
By Jonathan D. Rockoff
Moderna Inc. said it will be able to make at least 600 million doses of its Covid-19 vaccine this year, 100 million more than it had been projecting.
The… | January 5, 2021
Moderna Raises Covid-19 Vaccine Production Estimate
Moderna Inc. said it will be able to make at least 600 million doses of its Covid-19 vaccine this year, 100 million more than it had been projecting.
Moderna to supply Israel with vaccine ‘shortly’
The US biotech company last night reported that its mRNA vaccine has received Israeli Ministry of Health approval.
Why Did Novavax Stock Decline 20% In December?
Vaccine specialist Novavax – which is seen as a key player in the Covid-19 vaccine space – saw its stock price decline by about 20% over December. Here are a few possible reasons for the decline. Covid-19 vaccines by Pfizer and Moderna received emergency approval from the U.S. FDA in December…
Active Traders Look to Biotech for 2021
Due to lucrative risk/reward setups and heightened fundamental demand, many active traders will be watching biotech stocks.
Why Is Europe Paying a Lot Less Than the U.S. for COVID Vaccines?
There’s one compelling reason.
A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates
Scams include emails promising entry to supposedly secret lists for early vaccine access and robocallers impersonating government agencies. Message boards on the so-called dark web have added COVID-19 vaccines to more traditional illicit goods for sale.
Stocks making the biggest moves in the premarket: Micron Technology, First Solar, Moderna & more
The stocks making the biggest moves in premarket trading include Micron Technology, First Solar, Moderna, and more.
Why Is Everyone Talking About Arcturus Therapeutics Stock?
This clinical-stage biotech has been a wild ride for investors, and the shifting outlook for its COVID-19 vaccine candidate is the reason why.
Slaoui proposes half-doses of Moderna’s COVID-19 vaccine to speed vaccinations
A government official suggested that Americans should be given half-doses of Moderna Inc.’s COVID-19 vaccine in order to speed up the number of immunizations…
5 Ultra-Popular Stocks That Could Lose 50% (or More) in 2021
These high-flying stocks are long overdue for a reality check.
FDA Warns Against Tinkering With Pfizer, Moderna Vaccine Regimens After White House Advisor’s Comments
The United States Food and Drug Administration has warned against changing the dosing regimen, interval, or mixing of COVID-19 vaccines in a statement …
Israeli health ministry okays Moderna’s COVID-19 vaccine
Israel has begun to vaccinate its population at one of the quickest rates in the world, and it aims to reach all vulnerable citizens by late January
Moderna to produce at least 600 million doses of Covid-19 vaccine in 2021
Read more about Moderna to produce at least 600 million doses of Covid-19 vaccine in 2021 on Business Standard. US pharmaceutical company Moderna said it plans to produce at least 600 million doses of its vaccine against Covid-19 in 2021, not 500 million as previously announced
Israel’s health ministry authorizes use of Moderna’s COVID-19 vaccine
Moderna has received authorization for its COVID-19 vaccine in the United States and Canada and additional authorizations are currently under review in the European Union, Singapore, Switzerland and the United Kingdom.
Moderna Lifts Its Estimate for 2021 Coronavirus Vaccine Production by 20%
Its new baseline case forecast for the year is 600 million doses.
Moderna vaccine: ‘A slower rollout than we were hoping’ for B.C., says Henry
B.C. officials plan to vaccinate 70,000 residents and staff at long-term care facilities by the end of January — nearly half of all British Columbians who are expected to receive their first dose against COVID-19 by month’s end.
The worst mistake Moderna investors can make right now
The COVID-19 vaccine could be the first of a long list of successes.
New Year’s Resolutions and Vaccine Distributions
New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021
New Year’s Resolutions and Vaccine Distributions
New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021
Why Moderna Stock Jumped Today
The drugmaker is ramping up its coronavirus vaccine production targets.
The IMX Score Rebounded In December, Demonstrating Growing Optimism Around Economic Recovery
TD Ameritrade’s Investor Movement Index (IMX) — a monthly behavior-based index that indicates the attitude of retail investors — rebounded …
Arzneimittelbehrde EMA verschiebt Entscheidung zu Moderna-Impfstoff
Die Europische Arzneimittelbehrde EMA hat die Entscheidung ber die Empfehlung eines zweiten Corona-Impfstoffes fr die EU auf Mittwoch verschoben. Das teilte die EMA am Montagabend in Amsterdam mit. 04.01.2021
Monday’s Top 10 Gainers in Focus
U.S. stock futures rose in the pre-market Monday on optimism driven by the continued government stimulus and the availability of the Covid-19 vaccine….
U.S. heads toward 21 million COVID-19 cases and 353,000 deaths as vaccine program continues to lag all targets
The global case tally for the coronavirus-borne illness COIVID-19 climbed above 85 million on Monday, as the U.S. headed toward 21 million cases and 353,000…
New York Gov. Cuomo to propose law making it a crime to skip the line for Covid vaccine
Grab Falling Moderna Shares as the Vaccine Rollout Goes Global
MRNA stock isn’t under the radar any longer, but it is priced below where it ought to be as Covid-19 vaccines will remain in heavy demand.
Moderna Raises COVID-19 Vaccine Supply Estimate, Sending Stock Higher
Moderna Inc (NASDAQ: MRNA) shares were advancing Monday after the coronavirus vaccine manufacturer issued an update on its supply goals.
What Happened: …
U.S. heads toward 21 million COVID-19 cases and 352,000 deaths as vaccine program continues to lag all targets
The global case tally for the coronavirus-borne illness COIVID-19 climbed above 85 million on Monday, as the U.S. headed toward 21 million cases and 352,000…
Dr. Scott Gottlieb says Covid vaccine eligibility should be expanded now to deliver more shots
“You need to stockpile something,” the former FDA chief told CNBC on Monday. “But putting away 50% of all the doses, I think, is denying more people access.”
Why Is It Moving? Looking Into Why Moderna’s Stock is Trading Higher Today
The Price And Volume Action In Moderna’s Stock Today
Moderna (NASDAQ: MRNA) is currently up 5.0% to a price of $109.61. The stock’s volume is …